The quadrivalent vaccine has been shown to be safe and efficacious against HPV infection
in men. It is expected, though, that male vaccination rates will remain low. Therefore this …

Human papillomavirus (HPV) is an extremely prevalent sexually transmitted infection that is
typically acquired soon after onset of sexual activity. The burden of HPV-related malignant …

Human papillomavirus (HPV) vaccines have been shown to be both highly effective and
safe, and there is now considerable enthusiasm among healthcare providers to use the …

The most common cause of mortality related to human papillomavirus (HPV) infection is
cervical cancer. However, male HPV infection is also an important concern, both for the …

Background: For human papillomavirus (HPV) vaccination to have maximum benefit to
public health, both men and women should be vaccinated. Although efficacy trials in men …

The quadrivalent human papillomavirus virus vaccine was recently licensed for use in males
in the United States. This study reviews available published literature on acceptability …

OBJECTIVE: Recent scientific advances have lead to the development of a prophylactic,
quadrivalent HPV vaccine conferring. We surveyed Latino and non-Latino women directly to …

Human papillomaviruses are DNA viruses that infect skin or mucosal cells. In the genital
tract HPV (especially types 6 and 11) cause genital warts, the commonest viral sexually …

Men are at high risk for HPV infection and can benefit from vaccination, but vaccination rates
among men remain extremely low. More research needs to be done on the predictors of …

Objectives: HPV vaccine acceptability was examined as part of a cohort study of HPV
infection among adult males. Methods: Between July 2004 and June 2007, 445 adult males …